According to the World Health Organisation (WHO), an unknown illness has emerged in the Democratic Republic of Congo, ...

Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase ...

Introduction Gastroschisis mortality is disproportionately high in Africa due in part to delayed presentation and limited ...

LUMBASHI-(MaraviPost)-A highly anticipated derby between TP Mazembe and FC Saint Eloi Lupopo was abandoned on Sunday,March 08,2026 after violent clashes erupted among supporters during the match in ...

TEHRAN-(MaraviPost)-Iran has announced that it will not participate in the upcoming 2026 FIFA World Cup, citing escalating political and security tensions with the United States. The announcement was ...

African countries must not sign away their health data or release their pathogens in exchange for donor funding.

A single-dose pill called acoziborole cured most sleeping sickness patients in a major trial, even when the parasite reached the brain.

Three patients recovered from mpox, while the sole confirmed case of Crimean-Congo haemorrhagic fever (CCHF) in Omaheke proved fatal.